Envarsus

District Court Rules for FDA in Battle Over the Scope of 3-Year Exclusivity in the Context of Dueling Tacrolimus NDAs
FDA Law Blog
Wed, 06/17/15 - 06:36 pm
FDA
exclusivity
Astellas
Veloxis
kidney transplants
Envarsus
Veloxis Pharmaceuticals submits NDA to US FDA to market Envarsus for kidney transplant recipients
Pharmabiz.com
Tue, 12/31/13 - 11:36 am
FDA
Veloxis
Envarsus
kidney translants